Arax Advisory Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-174	Closed	-$2.89K	–	3030
2025 Q1	$2.89K	Buy	174 +129	+287%	+$2.14K	﹤0.01%	1963
2024 Q4	$826	Buy	45 +1	+2%	+$18	﹤0.01%	2213
2024 Q3	$677	Hold	44	–	–	﹤0.01%	2350
2024 Q2	$715	Buy	+44	New	+$715	﹤0.01%	2262